Global Clinical Immunodiagnostics Market will achieve a US$ 8.4 billion valuation by 2033, with a projected CAGR of approximately 5.3%
The global clinical immunodiagnostics market demand was estimated to be worth US$ 5.0 billion in 2023, and by 2033, it is anticipated to be worth US$ 8.4 billion. With a market share of more than 67.0%, the immunoassay kits & reagents segment now dominates the global market within the product category. From 2023 to 2033,…
